Monoamine oxidase inhibitors. I. 1-Alkyl and 1-aralkyl-2-(picolinoyl and 5-methyl-3-isoxazolyl-carbonyl)hydrazines. 1960

T S GARDNER, and E WENIS, and J LEE

UI MeSH Term Description Entries
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide

Related Publications

T S GARDNER, and E WENIS, and J LEE
January 1962, Acta poloniae pharmaceutica,
T S GARDNER, and E WENIS, and J LEE
May 1971, Bulletin de la Societe chimique de France,
T S GARDNER, and E WENIS, and J LEE
July 1976, Il Farmaco; edizione scientifica,
T S GARDNER, and E WENIS, and J LEE
March 1969, Journal of medicinal chemistry,
T S GARDNER, and E WENIS, and J LEE
December 1960, Science (New York, N.Y.),
T S GARDNER, and E WENIS, and J LEE
July 1962, Arzneimittel-Forschung,
T S GARDNER, and E WENIS, and J LEE
October 1968, Diabetes,
T S GARDNER, and E WENIS, and J LEE
March 1964, Journal of medicinal chemistry,
Copied contents to your clipboard!